Enhancing oxaliplatin-based regimens in colorectal cancer by inhibiting the epidermal growth factor receptor pathway

George P. Kim, Axel Grothey

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Enhancing oxaliplatin-based regimens in colorectal cancer by inhibiting the epidermal growth factor receptor pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences